The Patent Finder

Xenerex Biosciences

Also on record
Records under this name other than patents Xenerex Biosciences holds now: patents now held by others, patents whose terms have ended, and its applications, pending or abandoned.

Showing 1 to 4 of 4 · Back to Xenerex Biosciences

Confidence:Highevery input resolvedMediumone input unresolvedLowtwo or more caveatsUSPTO recordfrom USPTO's bulk records, without the patent's file history
PatentTitleStatus Expires Confidence
US 6,537,809Neutralizing high affinity human monoclonal antibodies specific to RSV F-protein and methods for their manufacture and therapeutic use thereof
Lapsed on the fee record
Ended Mar 25, 2015 · USPTO record
Lapsed on the fee recordEnded Mar 25, 2015USPTO record
US 5,476,996Human immune system in non-human animal
Term ended
Term ended no later than Dec 19, 2015 · Low confidence
Term endedTerm ended no later than Dec 19, 2015Low confidence
US 5,698,767Human immune system in non-human animal
Term ended
Term ended no later than Dec 16, 2017 · Low confidence
Term endedTerm ended no later than Dec 16, 2017Low confidence
US 5,958,765Neutralizing high affinity human monoclonal antibodies specific to RSV F-protein and methods for their manufacture and therapeutic use thereof
Term ended
Term ended no later than Sep 28, 2019 · Low confidence
Term endedTerm ended no later than Sep 28, 2019Low confidence
The Patent Finder CompaniesExpirationsCalculatorWatchlistPricing MethodologyCorrectionsLegalPrivacysupport@thepatentfinder.com Updated Nov 21, 2026 · includes USPTO assignment data published Nov 20, 2026, status data published Nov 21, 2026 and grant & fee data published Nov 17, 2026 (weekly) Part of 137 Finder · © 2026 137 Finder LLC · Sources cited